Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
All fact checks
AI analysis

Fact check

“The DEA's definition of "accepted medical use" essentially equated it with FDA approval.”
UnverifiableConfidence: LOW

Reasoning

The excerpt from the Reason.com article cites the DEA's definition as being essentially the same as FDA approval for a drug's accepted medical use, confirming the claim.

On confidence: The provided source directly states that the DEA's definition of "accepted medical use" essentially equated it with FDA approval.

Important context

The article discusses how the DEA's definition aligns with FDA approval criteria, and notes a shift during the Biden administration toward a broader test involving clinical experience and scientific support.

Evidence

Supporting (1)

  • Tier 1 — Primary source
    Federal drug scheduling relies on vague criteria, GAO report finds

    similar to the evidence that the Food and Drug Administration (FDA) demands to approve a drug for prescription use, the DEA's definition essentially equated "accepted medical use" with FDA approval. During the Biden administration, the HHS…

Limitations

The assessment relies on a single secondary source; no primary DEA documentation was examined. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.

Last verified:
Oct 1, 2026, 5:28 AM CDT
Pipeline:
2.1.0
Claim type:
Factual

Where this claim appeared

Hazy Drug Classification Criteria Invite Dubious Bureaucratic Judgments

Reason · Jacob Sullum